Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SK-1404 for Nocturia Due to Nocturnal Polyuria
NCT03116191Phase 2Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Feb 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lazuvapagon in nocturia, sponsored by Sanwa Kagaku Kenkyusho Co., Ltd.. Started Feb 2017; status: completed.
02
Drugs
lazuvapagon
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT03116191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03116191.